These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8094081)

  • 1. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1993 Sep; 268(27):19965-72. PubMed ID: 8104183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
    Loo TW; Clarke DM
    Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
    Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
    J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1994 Mar; 269(10):7243-8. PubMed ID: 7907326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
    Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
    Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.
    Gros P; Dhir R; Croop J; Talbot F
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7289-93. PubMed ID: 1678520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins.
    Dhir R; Grizzuti K; Kajiji S; Gros P
    Biochemistry; 1993 Sep; 32(36):9492-9. PubMed ID: 8103679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
    J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles.
    Dhir R; Gros P
    Biochemistry; 1992 Jul; 31(26):6103-10. PubMed ID: 1352702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane topology of a cysteine-less mutant of human P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1995 Jan; 270(2):843-8. PubMed ID: 7822320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
    Choi KH; Chen CJ; Kriegler M; Roninson IB
    Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
    Ruth A; Stein WD; Rose E; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
    Azzaria M; Schurr E; Gros P
    Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance.
    Devine SE; Ling V; Melera PW
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4564-8. PubMed ID: 1350094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.
    Loo TW; Clarke DM
    J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
    Devault A; Gros P
    Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence.
    Kast C; Canfield V; Levenson R; Gros P
    J Biol Chem; 1996 Apr; 271(16):9240-8. PubMed ID: 8621583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning.
    Hanna M; Brault M; Kwan T; Kast C; Gros P
    Biochemistry; 1996 Mar; 35(11):3625-35. PubMed ID: 8639515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
    Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.